Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241411792 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Maria Cristina Rapanotti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomic Pathology, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Melanoma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Rome Tor Vergata.
Abstract (Originalsprache)
The most promising method for monitoring patients with minimal morbidity is the detection of circulating melanoma cells (CMCs). We have shown that CD45−CD146+ABCB5+ CMCs identify a rare primitive stem/mesenchymal CMCs population associated with disease progression. The epithelial-to-mesenchymal transition (EMT) confers cancer cells a hybrid epithelial/mesenchymal phenotype promoting metastatization. Thus, we investigated the potential clinical value of the EMT gene signature of these primitive CMCs. A reliable quantitative real-time polymerase chain reaction (qRT-PCR) protocol was settled up using tumor cell lines RNA dilutions. Afterwards, immune-magnetically isolated CMCs from advanced melanoma patients, at onset and at the first checkpoint (following immune or targeted therapy), were tested for the level of EMT hallmarks and EMT transcription factor genes. Despite the small cohort of patients, we obtained promising results. Indeed, we observed a deep gene rewiring of the EMT investigated genes: in particular we found that the EMT gene signature of isolated CMCs correlated with patients’ clinical outcomes. In conclusion, We established a reliable qRT-PCR protocol with high sensitivity and specificity to characterize the gene expression of isolated CMCs. To our knowledge, this is the first evidence demonstrating the impact of immune or targeted therapies on EMT hallmark gene expressions in CMCs from advanced melanoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomic Pathology, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
- Department of Laboratory Medicine, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
- Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
- Surgery Division, Department of Surgery Sciences, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
- Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy.
ORCID-Profile: Cosimo Di Raimondo, Gaetana Costanza, Augusto Orlandi, Anastasia De Luca, Luca Bianchi
Förderung
- University of Rome Tor Vergata
Zitieren
APA
Rapanotti, M. C., Cugini, E., Campione, E., Di Raimondo, C., Costanza, G., Rossi, P., Ferlosio, A., Bernardini, S., Orlandi, A., De Luca, A., & Bianchi, L. (2023). Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411792
Vancouver
Rapanotti MC, Cugini E, Campione E, Di Raimondo C, Costanza G, Rossi P, et al. Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411792
BibTeX
@article{Rapanotti2023,
author = {Rapanotti, Maria Cristina and Cugini, Elisa and Campione, Elena and Di Raimondo, Cosimo and Costanza, Gaetana and Rossi, Piero and Ferlosio, Amedeo and Bernardini, Sergio and Orlandi, Augusto and De Luca, Anastasia and Bianchi, Luca},
title = {Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241411792}
}
EUVIMED